ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Biopsy"

  • 2019 American Transplant Congress

    Correlation of Donor-Derived Cell-Free DNA with Histology and Molecular Diagnoses of Kidney Transplant Biopsies

    I. Moinuddin1, D. Kumar1, P. Halloran2, L. Kamal1, A. King1, P. Kimball1, M. Levy1, C. Bhati1, D. Massey1, G. Gupta1

    1VCU Medical Center, Richmond, VA, 2Alberta Transplant Genomics Applied Centre, Edmonton, AB, Canada

    *Purpose: Circulating donor-derived cell free DNA (cfDNA; Allosure, CareDx, USA), a non-invasive test that could detect rejection in kidney allografts was validated using histologic diagnoses(HDx).…
  • 2019 American Transplant Congress

    Surveillance Biopsy Utilization Reported Higher In Transplant Centers Performing Over 100 Kidney Transplants Per Year.

    D. M. Lee1, R. First1, S. Rose1, M. Abecassis2

    1Transplant Genomics Inc, Mansfield, MA, 2Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL

    *Purpose: To assess the frequency of surveillance biopsies in kidney transplant patients in transplant centers performing greater than 100 transplants per year, and to compare…
  • 2019 American Transplant Congress

    Absence of Non Alcoholic Fatty Liver Disease in Allografts from Morbidly Obese Donors: A Marker for Success?

    M. MacConmara, A. Mufti, S. Hanish, T. Kerr, P. Vagefi, C. Hwang

    Surgery (Division of Surgical Transplantation), UT Southwestern, Dallas, TX

    *Purpose: Livers from African-American, morbidly obese donors are less likely to be discarded. We examined the utility of pre-recovery liver biopsy as a predictive biomarker…
  • 2019 American Transplant Congress

    Borderline Changes in Kidney Allografts Represents a Non-Homogenous Cohort with Different Outcome

    P. Hruba1, J. Maluskova1, Z. Krejcik2, M. Merkerova-Dostalova2, V. Stranecky3, J. Klema4, K. Osickova1, M. Wohlfahrtova1, E. Honsova1, O. Viklicky1

    1Institute for Clinical and Experimental Medicine, Prague, Czech Republic, 2Institute of Hematology and Blood Transfusion, Prague, Czech Republic, 3Institute of Inherited Metabolic Disorders, Prague, Czech Republic, 4Czech Technical University, Prague, Czech Republic

    *Purpose: Borderline changes (BL) represent a frequent histological finding in kidney allograft with unclear prognosis.*Methods: In this single center, retrospective, observational study, the BL were…
  • 2019 American Transplant Congress

    Is HLA Donor-Specific Antibody (DSA)-C3d+ Assay a Potential Predictor of Subclinical Antibody Mediated Damage in the Renal Graft?

    A. G. Contreras1, M. I. Solis-G1, C. Ramirez-Espinoza1, J. Hernandez-Rosales2, M. Vilatoba-Chapa1, R. Cruz-Martínez1, J. Granados1, L. E. Morales-Buenrostro3, J. Alberú1, J. M. Arreola-Guerra4

    1Transplantation, Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico, 2Department of Histocompatibility, Laboratorio Clinico del Campestre, Mexico City, Mexico, 3Nephrology-Mineral Metabolism, Instituto Nacional de Ciencias Medicas y Nutricion SZ, Mexico City, Mexico, 4Internal Medicine, Centenario Hospital Miguel Hidalgo, Mexico City, Mexico

    *Purpose: The Aim of the study was to explore the predictive value of the C3d assay for tissue damage in kidney transplant recipients (KTR) in…
  • 2019 American Transplant Congress

    Single Cell Sequencing of Human Kidney Allograft

    H. Yang1, H. Suryawanshi2, M. Lagman1, M. Lubetzky1, A. Alonso1, S. Seshan1, T. Tuschl2, M. Suthanthiran1, T. Muthukumar1

    1Weill Cornell Medicine, New York, NY, 2Rockefeller University, New York, NY

    *Purpose: Transcriptome-based clustering of individual cells within the kidney allograft may help identify cell type-specific injury and has the potential to redefine the current histopathology-based…
  • 2019 American Transplant Congress

    Proteomics Reveals Compartment-Specific Alterations in the Extracellular Matrix of Kidney Allografts with Antibody-Mediated Rejection

    S. Clotet Freixas1, C. McEvoy1, I. Batruch2, M. Kotlyar3, C. Pastrello3, J. Van1, A. Bozovic1, V. Kulasingam1, P. Chen4, I. Jurisica3, A. Chruscinski1, R. John1, A. Konvalinka1

    1University Health Network, Toronto, ON, Canada, 2Lunenfeld-Tanenbaum Research Institute, Toronto, ON, Canada, 3Krembil Research Institute, Toronto, ON, Canada, 4Institute of Medical Science, University of Toronto, Toronto, ON, Canada

    *Purpose: Antibody-mediated rejection (AMR) is the most important cause of premature kidney graft loss. AMR is caused by anti-HLA and non-HLA antibodies against proteins in…
  • 2019 American Transplant Congress

    Post-Reperfusion Hepatic Beta-Catenin Activation Regulates Graft Damage, Inflammatory Responses and Transplant Outcomes

    H. Hirao, K. Kadono, S. Kageyama, K. Nakamura, T. Ito, J. Aziz, K. J. Dery, F. M. Kaldas, R. W. Busuttil, J. W. Kupiec‐Weglinski

    Dumont-UCLA Transplant Center, UCLA, Los Angeles, CA

    *Purpose: Hepatic ischemia-reperfusion injury (IRI), an innate-immune driven hepatic inflammation response, represents a major risk factor of early allograft dysfunction (EAD) and rejection in liver…
  • 2019 American Transplant Congress

    First UK Experience of the Molecular Microscope (MMDX™) in the Kidney Transplant Clinic

    C. Lawrence1, S. Thiru2, A. Manoj1, S. Fluck1

    1Renal Medicine, The Lister Hospital, Stevenage, United Kingdom, 2Histopathology, Addenbrookes Hospital, Cambridge, United Kingdom

    *Purpose: Molecular diagnostic methods are now included in the Banff classification of kidney transplant pathology. Traditional histopathology may be limited by intra/inter pathologist variation. The…
  • 2019 American Transplant Congress

    Subclinical Rejection is Common on Surveillance Biopsies in Children with Kidney Transplant

    S. Gattis1, R. Liverman1, A. Serluco1, J. Yin1, J. Hogan2, S. Jernigan2, R. George2, P. D. Winterberg2, R. Garro2

    1Children's Healthcare of Atlanta, Atlanta, GA, 2Department of Pediatrics, Emory University School of Medicine, Atlanta, GA

    *Purpose: Surveillance biopsies provide the opportunity to identify subclinical rejection and other pathologic changes, yet their utilization varies across pediatric kidney transplant centers. The purpose…
  • « Previous Page
  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 43
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences